What the business is, and whether it's a good one at a fair price.
Designs, develops and manufactures precision-engineered plastic components and finished drug-delivery devices across healthcare, consumer durables and industrial segments. The healthcare business surged 139% in FY26 to INR393 crore and contributed 40% of consolidated revenue, anchored on the proprietary ShailyPen Neo spring-driven pen injector platform used in Semaglutide combination products — the firm handles full design-to-manufacture of device components for pharma partners and has secured a INR423 crore pen injector order over 4 years, holding 70% share among the top-6 Canadian filers. Consumer durables revenue stood at INR511 crore in FY26 (down 9% YoY), and industrial revenue at INR87 crore (up 41% YoY). FY26 consolidated revenue was INR991 crore, exports contributing ~68%, and machine utilisation reaching 47.6%. New vertical entry includes semiconductor trays (sole Indian manufacturing partner for a Korean customer, supplies from Q4 FY27) and consumer electronics precision components (a ~INR100 crore South India plant). A 25 million pen capacity line is ramping, with a second 25 million line due Jul-Aug 2026; pen volume targets are 36 million in FY27 and ~50 million in FY28. Materials are the largest cost at 44% of revenue, capex runs at 18% of revenue, and the board has approved an enabling resolution to raise up to INR500 crore.
Measured from the filed financials, judged against its Plastic Products - Consumer peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from SHAILY ENG PLASTICS LTD's filed financials and exchange disclosures
SHAILY ENG PLASTICS LTD is a Consumer Durables company listed on NSE and BSE, trading under the symbol SHAILY.
Yes. Over the trailing twelve months SHAILY ENG PLASTICS LTD reported a net profit of ₹177 Cr on revenue of ₹1,025 Cr.
Yes. The dividend yield is 0.06% at the current price. It paid out 5% of its profit as dividend in FY26.
No. Debt stands at 0.24× equity, and it carries net debt of ₹153 Cr. That is lower than 29% of its 8 Plastic Products - Consumer peers.
On trailing P/E, SHAILY ENG PLASTICS LTD ranks 8 of 8 in Plastic Products - Consumer — cheaper than 0% of them, against an industry median of 16.9×. This is a position, not a valuation judgement.
On a typical session SHAILY ENG PLASTICS LTD moves 1.57% — that is the median absolute close-to-close move across its last 269 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by SHAILY ENG PLASTICS LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
